Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Penpulimab by Akeso for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
Penpulimab is under clinical development by Akeso and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...
Penpulimab by Akeso for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
Penpulimab is under clinical development by Akeso and currently in Phase II for Metastatic Adenocarcinoma of The Pancreas. According to...
Penpulimab by Akeso for Cervical Cancer: Likelihood of Approval
Penpulimab is under clinical development by Akeso and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II...
Penpulimab by Akeso for Non-Small Cell Lung Cancer: Likelihood of Approval
Penpulimab is under clinical development by Akeso and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...